Ke Ning

Papers

Total Citations

H-Index

About

Ke Ning is a prominent surgical oncologist whose research centers on the management of head and neck cancers, with a particular focus on human papillomavirus (HPV)-related oropharyngeal malignancies. Dr. Ning’s major contributions lie in refining treatment paradigms for HPV/p16-positive oropharyngeal cancer, especially through the lens of transoral robotic surgery (TORS). Their landmark 2020 study, cited 27 times, critically evaluated the roles of surgical margins, extra-nodal extension, and adjuvant therapy in this patient population, providing evidence-based guidance for de-escalating treatment while maintaining oncologic control. This work has helped shape clinical decision-making, balancing the need for curative resection with the imperative to minimize long-term toxicity in younger, healthier patients. By systematically analyzing pathological risk factors, Dr. Ning has advanced personalized surgical strategies, demonstrating that careful patient selection can reduce unnecessary adjuvant radiation or chemotherapy. Their research continues to influence multidisciplinary approaches to oropharyngeal cancer, making them a key voice in the evolving conversation around HPV-related disease management. Dr. Ning’s work underscores a commitment to improving outcomes through precision surgery and thoughtful risk stratification.